Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1980 | 12-1979 | 12-1978 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 3,766 | 548 | N/A |
| Receivables | 9,351 | 8,734 | N/A |
| Inventories | 9,665 | 8,255 | N/A |
| Other current assets | 502 | 529 | 0 |
| TOTAL | $23,284 | $18,066 | $N/A |
| Non-Current Assets | |||
| PPE Net | 6,642 | 5,702 | N/A |
| Investments And Advances | 6,693 | 0 | 0 |
| Other Non-Current Assets | 1,070 | 637 | 0 |
| TOTAL | $14,405 | $6,339 | $N/A |
| Total Assets | $37,689 | $24,405 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 271 | 934 | N/A |
| Accounts payable and accrued liabilities | 3,071 | 2,724 | 0 |
| Other current liabilities | 3,731 | 3,075 | N/A |
| TOTAL | $7,589 | $8,190 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 15,536 | 7,281 | N/A |
| TOTAL | $16,424 | $8,384 | $N/A |
| Total Liabilities | $24,013 | $16,574 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 2,831 | 2,498 | N/A |
| Retained earnings | 6,582 | 4,853 | N/A |
| Other shareholders' equity | 0 | -258 | 0 |
| TOTAL | $13,676 | $7,831 | $N/A |
| Total Liabilities And Equity | $37,689 | $24,405 | $0 |